|
The
National Suprapubic Catheter Insertion audit has now been updated
to include unplanned / acute procedures and all existing data
transferred to the web-based database. No
paper returns can now be accepted. Login to the new system here : https://audits.baus.org.uk
The Botulinum Toxin audit
has been transferred to the web-based database. Paper proformas will no
longer be accepted and will be returned to sender.
The
surgical procedures dataset has been discontinued. Returns have failed to increase since the re-launch and
it is anticipated that it would be replaced by the proposed
e-logbook about which the committee is currently seeking clarification.
1.
National Suprapubic Catheter Insertion Audit (from 1.1.2010)
Number
of audits entered as of 1st October 2010: 477
The
aim of this audit is to produce definitive data on the safety/risks of
both elective
and emergency suprapubic catheter insertion. We know
that this “ simple” intervention can be associated with significant
complications but do not have reliable data which can be used to counsel
patients. Data on a large number of
procedures (500 is a realistic aspiration) would provide the necessary
information. Furthermore, the data will
be helpful in informing guidelines regarding catheter insertion techniques in
particular clinical situations (such as the patient who has had previous lower
abdominal surgery).
2. National Botulinum Toxin Therapy Audit -
Number
of proformas returned as of 1st October 2010: 202
Botulinum toxin injection therapy for
detrusor overactivity (and other indications) has entered urological practice
in a widespread but unstructured manner.
Limited numbers of high-quality controlled trials are available to
complement published case series. Now
botulinum toxin is “out there”, there is a need to gain a clear picture as to
its use, effectiveness and complications.
This audit is designed to collect data on a very large number of
treatments (perhaps as many as 1,000) and thereby generate information that is
of international importance. Simple
outcome measures are included which will provide data on the proportion of
“real world” patients who respond to treatment and, importantly, the duration
of responses.
|
